Bill > HB785

This bill creates new provisions in Missouri law regulating how health carriers and pharmacy benefits managers (PBMs) interact with 340B drug program participants. The 340B drug program is a federal initiative that allows certain healthcare providers (like hospitals and community health centers) to purchase prescription drugs at significantly discounted prices. The bill prohibits health carriers and PBMs from discriminating against 340B covered entities by implementing several specific protections, such as: preventing lower reimbursement rates for 340B drugs compared to other pharmacies, prohibiting interference with patients' choice to receive 340B drugs, ensuring reimbursement rates are at least equal to national average drug acquisition costs, and blocking requirements that force covered entities to identify 340B drugs. The legislation mandates that any contracts violating these provisions will be void, allows the director of the Department of Commerce and Insurance to impose civil penalties up to $5,000 per violation per day, and requires the development of specific rules to implement these protections. The bill aims to preserve the financial benefits of the 340B drug program for qualifying healthcare providers by preventing practices that could undermine the program's intended discounts and cost savings.

https://house.mo.gov/Bill.aspx?bill=HB785&year=2025&code=R